Caplyta (lumateperone) and Vraylar (cariprazine) are brand-name oral capsules. They’re both prescribed for schizophrenia and depressive episodes of bipolar disorder. This article explains the main ...
Caplyta (lumateperone) and Vraylar (cariprazine) are prescription drugs used to treat schizophrenia and bipolar depression. Both drugs come as capsules that you take once per day. Caplyta and Vraylar ...
Caplyta is a brand-name prescription drug used to treat certain mental health conditions. It is a type of drug called an atypical antipsychotic. If a person has a Part D prescription drug plan or a ...
What Is Caplyta, and Why Does It Matter? Caplyta (lumateperone) is a once-daily oral medicine now approved to be used with antidepressants to treat major depressive disorder (MDD) in adults. It ...
CAPLYTA® ranked highest among FDA-approved adjunctive therapies across four measures of efficacy, based on indirect comparisons from placebo plus antidepressant therapy-controlled trials Among the ...
TITUSVILLE, N.J., April 27, 2026 /PRNewswire/ -- Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) based on ...
Caplyta is a brand-name prescription medication containing the active ingredient lumateperone. Currently, no generic version of the medication is available. An important note about Caplyta for older ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results